Skip to content

Rohini Chakravarthy

NPI 1063944668ActiveIndividual· Pediatrics, Pediatric Hematology-Oncology· Chicago, IL

Pediatrics, Pediatric Hematology-Oncology in Chicago, Illinois, licensed in IL, with an NPI issued in April 2017. Part D covered 207 prescriptions written in 2024, 87% of them generic. Syndax Pharmaceuticals, Inc. reported $85.65 in payments in 2025, mostly food and beverage.

Overview

NPI1063944668
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedApr 1, 2017
Last updated in NPPESSep 18, 2024
Certified by providerSep 18, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Hematology-Oncology Primary2080P0207X036171829IL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (IL)

Part D prescriptions in 2024

Prescriptions (claims)207 · 302 30-day fills
Patients12
Total drug cost$20,613
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$85.65 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Syndax Pharmaceuticals, Inc.$85.651

What the 2025 payments were for

  • Food and Beverage$85.65 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Hematology-Oncology providers in Chicago

All Pediatrics, Pediatric Hematology-Oncology providers in Illinois →